Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform-Reference-Cited by-同舟云学术

Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform

Published:2021-01 Issue:1 Volume:3 Page:e19-e27
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Rentsch Christopher T,DeVito Nicholas J,MacKenna Brian,Morton Caroline E,Bhaskaran Krishnan,Brown Jeremy P,Schultze Anna,Hulme William J,Croker Richard,Walker Alex J,Williamson Elizabeth J,Bates Chris,Bacon Seb,Mehrkar Amir,Curtis Helen J,Evans David,Wing Kevin,Inglesby Peter,Mathur Rohini,Drysdale Henry,Wong Angel Y S,McDonald Helen I,Cockburn Jonathan,Forbes Harriet,Parry John,Hester Frank,Harper Sam,Smeeth Liam,Douglas Ian J,Dixon William G,Evans Stephen J W,Tomlinson Laurie,Goldacre Ben

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference25 articles.

1. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro;Liu;Cell Discov,2020

2. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Yao;Clin Infect Dis,2020

3. Effect of hydroxychloroquine in hospitalized patients with Covid-19;N Engl J Med,2020

4. Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial;Mitjà;Clin Infect Dis,2020

5. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial;Skipper;Ann Intern Med,2020

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review;Clinical Pharmacology: Advances and Applications;2024-01

2. Impact of the COVID-19 pandemic on dispensing medicines in the community pharmacy;International Journal of Risk & Safety in Medicine;2023-12-07

3. Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY;BMJ Mental Health;2023-09

4. Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review;Current Rheumatology Reports;2023-08-19

5. Hydroxychloroquine reduces T cells activation recall antigen responses;PLOS ONE;2023-08-02